Artificial Pancreas Device System Market 2022 Key Vendors, Analysis by Growth and Revolutionary Opportunities by 2030

Comments · 564 Views

Artificial Pancreas Device System Market size stood at USD 171.04 Million in 2020 and is projected to reach USD 990.51 million by the end of 2030 exhibiting a CAGR of 19.2% over the forecast period of 2021 to 2030.

A continuous glucose monitoring system (CGM) and an insulin infusion pump are the two different forms of diabetes monitoring equipment included in Artificial Pancreas Device Systems. a blood glucose measuring instrument used to calibrate the CGM, such as a glucose metre. When a person's blood glucose level falls below a certain level, these devices automatically suspend insulin treatment for up to two hours if the person does not react to the threshold-suspension alarm. This is meant to decrease hypoglycemic excursions. The FDA approved the hybrid closed loop insulin delivery system MiniMed 670G System (Medtronic) in 2016. The first artificial pancreas system with full automation is this gadget.

Human-made bio-artificial organs known as artificial organs are inserted into the body to assist or replace natural organs. Cochlear implants, artificial kidneys, pancreas, and hearts are examples of artificial organs. They are constructed from biocompatible substances like metals, ceramics, polymers, and biologics. Different technologies, including sensors, biomaterials, and cutting-edge delivery systems, are implanted in artificial pancreas. Additionally, artificial pancreas lets the patient live a quality life by performing the same functions as the natural pancreas.

Artificial Pancreas Device System Market: Segmentation Analysis

Artificial Pancreas Device System Market based on device type

  • Threshold suspend device systems
  • Control- to-Range systems (CTR)
  • Control-to- Target systems (CTT)

The threshold suspends device system segment led the Artificial Pancreas Device System market and accounted for a major global revenue share in 2015. This high share is attributed to its ability to take an instant action automatically when the patient is not able to respond to threshold suspend alarm, and it stops insulin supply as soon as sensor glucose reaches a low threshold.

CTT system is expected to register substantial growth with a CAGR of 37.6% over the forecast period. This growth can be credited to the CTT system attributes, such as its automation system, minimizing patient intervention. These factors are projected to drive the growth of the global Artificial Pancreas Device Market.

Artificial Pancreas Device System Market based on treatment type

  • Bi-hormonal
  • Insulin Only
  • Hybrid

Artificial Pancreas Device System Market based on end-user

  • Hospital
  • Medical Centers
  • Others

The Hospital segment dominated the market for Artificial Pancreas devices and held the largest revenue share in 2020. The segment is expected to maintain its dominance over the forecast period. This growth can be credited to the growing investment in the construction of hospitals with advanced technology and equipment.

Get Free Sample:- https://wemarketresearch.com/sample-request/artificial-pancreas-device-system-market/31/

Top Key Players:-

  • Johnson Johnson
  • Beta Bionics
  • Bigfoot Biomedical
  • Admetsys (pipeline product analysis)
  • Animas Corporation
  • Defymed
  • dexcom
  • Insulet
  • MedTech
  • Semma Therapeutics
  • Tandem Diabetes Care
  • TypeZero Technologies
  • Pancreum, Inc.
  • Cellnovo
  • Hoffeman-La Roche Ltd
  • Inreda Diabetic B.V.
  • Roche Holding AG
  • Medtrum Technologies Inc.
  • DreaMed Diabetes Ltd

Interested in purchasing this Report? Click here:- https://wemarketresearch.com/purchase/artificial-pancreas-device-system-market/31/?license=single

Frequently Asked Questions (FAQ):

  1. What is the study period of this market?
  2. What is the growth rate of Artificial Pancreas Device System Market?
  3. Which region has highest growth rate in Artificial Pancreas Device System Market?
  4. Which region has largest share in Artificial Pancreas Device System Market?
  5. Who are the key players in Artificial Pancreas Device System Market?

About We Market Research

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

Contact Us:

We Market Research

Phone: +1(929)-450-2887

Email: [email protected]  

Web: https://wemarketresearch.com/

Comments